日间小剂量递增腹膜透析对终末期肾病的治疗价值分析

Analysis of the treatment value of day small dose escalation peritoneal dialysis in end-stage renal disease

目的:探讨日间小剂量递增腹膜透析对终末期肾病的治疗价值。方法:收治终末期肾病患者62例,随机分为观察组和对照组各31例,观察组采取日间小剂量递增腹膜透析模式治疗,对照组采取持续标准剂量腹膜透析模式治疗。比较两组患者治疗前后胱抑素C、24 h尿量和每日透析液总量以及透析时间。结果:观察组每日透析液总量、透析时间和胱抑素C水平明显少于对照组,24 h尿量明显多于对照组(P<0.05)。结论:日间小剂量递增腹膜透析对终末期肾病的治疗效果显著,可改善患者残肾功能,减少透析液使用剂量,缩短透析时间。

Objective:To explore the treatment value of day small dose escalation peritoneal dialysis in end-stage renal disease.Methods:62 patients with end-stage renal disease were selected.They were randomly divided into the observation group and thecontrol group with 31 cases in each.The observation group was given day small dose escalation peritoneal dialysis mode treatment.The control group was given continuous standard dose peritoneal dialysis mode treatment.The cystatin C,24 hours urine volumebefore and after treatment and daily dialysate amount and dialysis time of two groups were compared.Results:The daily dialysateamount,dialysis time and cystatin C level of the observation group were significantly less than those of the control group;24 hoursurine volume was significantly higher than that of the control group(P<0.05).Conclusion:The day small dose escalation peritonealdialysis for end-stage renal disease has a significant treatment effect,which can improve the residual renal function of patients,reduce the using dose of dialysis fluid,and shorten the dialysis time.